digestive/alimentary system
• mice treated with the hapten oxazolone to induce colitis (a TH2/9 model of colitis) show reduced weight loss and colonic inflammation compared to wild-type mice
|
immune system
• mice treated with the hapten oxazolone to induce colitis (a TH2/9 model of colitis) show reduced weight loss and colonic inflammation compared to wild-type mice
|
• following oxazolone-induced colitis, mice show increased frequency and absolute number of Helios-Foxp3+CD4+ T cells in colonic tissue indicating increased colonic T-reg cells
|
• in the skin of IMQ-treated mice
|
• in the skin of IMQ-treated mice
• in skin-draining lymph nodes of IMQ-treated mice
|
• decreased IL17A-producing gamma-delta T cells in IMQ-treated mice
|
• in skin-draining lymph nodes of IMQ-treated mice
|
• reduced cellularity of skin-draining lymph nodes of IMQ-treated mice
|
• decreased IL17A-producing gamma-delta T cells in IMQ-treated mice
|
• following oxazolone-induced colitis, mice show reduced IL-9 production by colonic lamina propria lymphocytes
|
homeostasis/metabolism
• mice are protected from IMQ (Aldara)-induced psoriasis with decreased ear swelling, acanthosis, erythema, skin flaking and hyperkeratosis compared with wild-type mice
|
hematopoietic system
• following oxazolone-induced colitis, mice show increased frequency and absolute number of Helios-Foxp3+CD4+ T cells in colonic tissue indicating increased colonic T-reg cells
|
• in the skin of IMQ-treated mice
|
• in the skin of IMQ-treated mice
• in skin-draining lymph nodes of IMQ-treated mice
|
• decreased IL17A-producing gamma-delta T cells in IMQ-treated mice
|
• in skin-draining lymph nodes of IMQ-treated mice
|